肥胖与2型糖尿病：在治疗选择上也存在关联。
Obesity and type 2 diabetes: Also linked in therapeutic options.
作者信息
Rubio-Almanza Matilde, Cámara-Gómez Rosa, Merino-Torres Juan Francisco
机构信息
Servicio de Endocrinología y Nutrición, Hospital Universitari i Politècnic La Fe, Valencia, España; Unidad Mixta de Investigación en Endocrinología, Nutrición y Dietética Clínica, Instituto de Investigación Sanitaria La Fe, Valencia, España.
Servicio de Endocrinología y Nutrición, Hospital Universitari i Politècnic La Fe, Valencia, España; Unidad Mixta de Investigación en Endocrinología, Nutrición y Dietética Clínica, Instituto de Investigación Sanitaria La Fe, Valencia, España.
出版信息
Endocrinol Diabetes Nutr (Engl Ed). 2019 Mar;66(3):140-149. doi: 10.1016/j.endinu.2018.08.003. Epub 2018 Oct 15.
The prevalence of obesity has increased worldwide over the past decades. Obesity is associated with multiple comorbidities, such as type 2 diabetes, that generates a great impact on health and economy. Weight loss in these patients leads to glycemic control so it is a target to achieve. Lifestyle changes are not effective enough and recently other treatments have been developed such as bariatric/metabolic surgery, as well as drugs for type 2 diabetes and antiobesity drugs. The aim of this review is to compare the results in weight reduction and glycemic control of the different kinds of drugs with bariatric / metabolic surgery's results in type 2 diabetes.
在过去几十年里，肥胖症在全球范围内的患病率有所上升。肥胖与多种合并症相关，如2型糖尿病，这对健康和经济产生了巨大影响。这些患者体重减轻可实现血糖控制，因此这是一个需要达成的目标。生活方式的改变效果不够显著，最近已经开发出了其他治疗方法，如减肥/代谢手术，以及用于治疗2型糖尿病的药物和抗肥胖药物。本综述的目的是比较不同种类药物在减重和血糖控制方面的结果与减肥/代谢手术在2型糖尿病治疗中的结果。
Zotero 插件